{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:04:02Z","timestamp":1788851042231,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201908440363 Z.Z"],"award-info":[{"award-number":["201908440363 Z.Z"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["RCU_H_64_010_30"],"award-info":[{"award-number":["RCU_H_64_010_30"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["B16F640154"],"award-info":[{"award-number":["B16F640154"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.clim.2024.110312","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T02:10:21Z","timestamp":1721009421000},"page":"110312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A patient-based murine model recapitulates human STAT3 gain-of-function syndrome"],"prefix":"10.1016","volume":"266","author":[{"given":"Kornvalee","family":"Meesilpavikkai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasiphak","family":"Kaikaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suphattra","family":"Phakham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"van der Spek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Swagemakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deon J.","family":"Venter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"de Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Schrijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Schliehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgil A.S.H.","family":"Dalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Martin","family":"van Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattiya","family":"Hirankarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"IJspeert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Dik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clim.2024.110312_bb0005","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/ACI.0000000000000689","article-title":"Primary immune regulatory disorders: a growing universe of immune dysregulation","volume":"20","author":"Chan","year":"2020","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2024.110312_bb0010","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.clim.2024.110312_bb0015","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110312_bb0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.clim.2024.110312_bb0025","article-title":"STAT3 gain-of-function syndrome","volume":"10","author":"Vogel","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.clim.2024.110312_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.clim.2024.110312_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fimmu.2018.00168","article-title":"Signal transducer and activator of transcription 3 control of human T and B cell responses","volume":"9","author":"Deenick","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2024.110312_bb0040","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20151467","article-title":"Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets","volume":"213","author":"Ma","year":"2016","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.clim.2024.110312_bb0045","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat. Genet."},{"issue":"7188","key":"10.1016\/j.clim.2024.110312_bb0050","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.clim.2024.110312_bb0055","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clim.2024.110312_bb0060","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2741\/4054","article-title":"IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?","volume":"17","author":"Camporeale","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.clim.2024.110312_bb0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fimmu.2012.00020","article-title":"SOCS, inflammation, and autoimmunity","volume":"3","author":"Yoshimura","year":"2012","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2024.110312_bb0070","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaci.2023.02.010","article-title":"A multifaceted disease: the stats of STAT3 GOF","volume":"151","author":"Freeman","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2024.110312_bb0075","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.clim.2024.110312_bb0080","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.immuni.2022.11.001","article-title":"STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2D(hi) CD8(+) T cell dysregulation and accumulation","volume":"55","author":"Masle-Farquhar","year":"2022","journal-title":"Immunity"},{"issue":"21","key":"10.1016\/j.clim.2024.110312_bb0085","article-title":"A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice. JCI","volume":"7","author":"Schmitt","year":"2022","journal-title":"Insight"},{"issue":"8","key":"10.1016\/j.clim.2024.110312_bb0090","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210759","article-title":"A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance","volume":"218","author":"Warshauer","year":"2021","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.clim.2024.110312_bb0095","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4049\/jimmunol.2100920","article-title":"Cutting edge: systemic autoimmunity in murine STAT3 gain-of-function syndrome is characterized by effector T cell expansion in the absence of overt regulatory T cell dysfunction","volume":"209","author":"Woods","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110312_bb0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fimmu.2017.00274","article-title":"A novel heterozygous mutation in the STAT1 SH2 domain causes chronic Mucocutaneous candidiasis, atypically diverse infections, autoimmunity, and impaired cytokine regulation","volume":"8","author":"Meesilpavikkai","year":"2017","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2024.110312_bb0105","first-page":"368","article-title":"Low level IGF-1 and common variable immune deficiency: an unusual combination","volume":"66","author":"van Bilsen","year":"2008","journal-title":"Neth. J. Med."},{"issue":"24","key":"10.1016\/j.clim.2024.110312_bb0110","doi-asserted-by":"crossref","first-page":"20037","DOI":"10.18632\/oncotarget.5042","article-title":"A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation","volume":"6","author":"Wienke","year":"2015","journal-title":"Oncotarget"},{"issue":"7090","key":"10.1016\/j.clim.2024.110312_bb0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.clim.2024.110312_bb0120","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/ijms19030730","article-title":"The balance of Th17 versus Treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.clim.2024.110312_bb0125","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clim.2024.110312_bb0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","article-title":"Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome","volume":"122","author":"Renner","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7157","key":"10.1016\/j.clim.2024.110312_bb0135","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.clim.2024.110312_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.04.020","article-title":"Elucidating the effects of disease-causing mutations on STAT3 function in autosomal-dominant hyper-IgE syndrome","volume":"138","author":"Pelham","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110312_bb0145","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.mce.2018.01.016","article-title":"Partial growth hormone insensitivity and dysregulatory immune disease associated with de novo germline activating STAT3 mutations","volume":"473","author":"Guti\u00e9rrez","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"issue":"13","key":"10.1016\/j.clim.2024.110312_bb0150","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1021\/jp810009s","article-title":"Positively charged residues in DNA-binding domains of structural proteins follow sequence-specific positions of DNA phosphate groups","volume":"113","author":"Cherstvy","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.clim.2024.110312_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-biochem-060408-091030","article-title":"Origins of specificity in protein-DNA recognition","volume":"79","author":"Rohs","year":"2010","journal-title":"Annu. Rev. Biochem."},{"issue":"8","key":"10.1016\/j.clim.2024.110312_bb0160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/genes8080192","article-title":"Proteins recognizing DNA: structural uniqueness and versatility of DNA-binding domains in stem cell transcription factors","volume":"8","author":"Yesudhas","year":"2017","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.clim.2024.110312_bb0165","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.clinthera.2017.01.004","article-title":"Tocilizumab promotes regulatory T-cell alleviation in STAT3 gain-of-function-associated multi-organ autoimmune syndrome","volume":"39","author":"Khoury","year":"2017","journal-title":"Clin. Ther."},{"key":"10.1016\/j.clim.2024.110312_bb0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13223-020-00462-w","article-title":"The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations","volume":"16","author":"Lin","year":"2020","journal-title":"Allergy, Asthma Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110312_bb0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12865-021-00411-1","article-title":"Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Immunol."},{"key":"10.1016\/j.clim.2024.110312_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663177","article-title":"Essential role of STAT3 signaling in hair follicle homeostasis","volume":"12","author":"Miyauchi","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110312_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.clim.2024.110312_bb0190","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41467-017-01236-6","article-title":"Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.clim.2024.110312_bb0195","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/rheumatology\/kex347","article-title":"Role of STAT3 in skin fibrosis and transforming growth factor beta signalling","volume":"57","author":"Pedroza","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.clim.2024.110312_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030634","article-title":"Stress erythropoiesis is a key inflammatory response","volume":"9","author":"Paulson","year":"2020","journal-title":"Cells"},{"issue":"17","key":"10.1016\/j.clim.2024.110312_bb0205","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2012-06-439661","article-title":"Characterization of the TGF-beta1 signaling abnormalities in the Gata1low mouse model of myelofibrosis","volume":"121","author":"Zingariello","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clim.2024.110312_bb0210","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2006-08-040352","article-title":"Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis","volume":"109","author":"Jenkins","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110312_bb0215","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset Evans syndrome: heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2024.110312_bb0220","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201707-1500IM","article-title":"STAT3 gain of function: a new kid on the block in interstitial lung diseases","volume":"197","author":"Fabre","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.clim.2024.110312_bb0225","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clim.2017.11.007","article-title":"A novel de novo activating mutation in STAT3 identified in a patient with common variable immunodeficiency (CVID)","volume":"187","author":"Russell","year":"2018","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2024.110312_bb0230","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/edrv-15-4-516","article-title":"Insulin-dependent diabetes mellitus as an autoimmune disease","volume":"15","author":"Bach","year":"1994","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.clim.2024.110312_bb0235","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0167-5699(94)90154-6","article-title":"Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease","volume":"15","author":"Bowman","year":"1994","journal-title":"Immunol. Today"},{"issue":"3","key":"10.1016\/j.clim.2024.110312_bb0240","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/08916939309019929","article-title":"Influence of microbial agents on the development and prevention of autoimmune diabetes","volume":"15","author":"Singh","year":"1993","journal-title":"Autoimmunity"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624004212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624004212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:03:18Z","timestamp":1778616198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624004212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":48,"alternative-id":["S1521661624004212"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.110312","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A patient-based murine model recapitulates human STAT3 gain-of-function syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.110312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Erasmus Medical Center. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110312"}}